RTP firm adds $20B+ in value after Alzheimer's drug wins FDA approval

Triangle Business Journal

Jun 7, 2021

After months of anticipation, Biogen has won a coveted - but controversial - approval from the U.S. Food and Drug Administration for its blockbuster drug to treat early-onset Alzhe…